• 1
    Crawford MA, Schall WD, Jensen RK, et al. Chronic active hepatitis in 26 Doberman Pinschers. J Am Vet Med Assoc 1985;187:13431350.
  • 2
    Haywood S., Rutgers HC, Christian MK. Hepatitis and copper accumulation in Skye Terriers. Vet Pathol 1988; 28: 11271140.
  • 3
    Hultgren BD, Stevens JB, Hardy RM. Inherited chronic progressive hepatic degeneration in Bedlington Terriers with increased copper concentrations: Clinical and pathologic observations and comparison with other copper associated liver diseases. Am J Vet Res 1986;47:365377.
  • 4
    Thornburg LP, Rottinghaus G., Dennis G., et al. The relationship between hepatic copper content and morphological changes in the liver of West Highland White Terriers. Vet Pathol 1996;33:656661.
  • 5
    Twedt D., Sternlieb I., Gilbertson SR. Clinical, morphologic and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc 1979;175:269275.
  • 6
    Webb CB, Twedt D., Meyer DJ. Copper associated liver disease in Dalmations: A review of 10 dogs (19982001). J Vet Intern Med 2002;16: 665668.
  • 7
    Fuentealba IC, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol, Available at: http:www.comparative-hepatology.comcontent215. Accessed October 24, 2006
  • 8
    Mandiger PJ, van den Ingh TS, Spee B., et al. Chronic hepatitis in Doberman Pinschers: A review. Vet Q 2004;26:98106.
  • 9
    Thornburg LP. Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet Pathol 1998;35:380385.
  • 10
    Sevelius E., Andersson M., Jönsson L. Hepatic accumulation of alpha-1-antitrypsin in chronic liver disease in the dog. J Comp Path 1994;111:401412.
  • 11
    Watson PJ. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression and treatment. Vet J 2004;167:228241.
  • 12
    Andersson M., Sevelius E. Breed, sex, and age distribution in dogs with chronic liver disease: A demographic study. J Small Anim Pract 1991;32:15.
  • 13
    WSAVA Liver Standardization Group. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. Toronto , Canada : Elsevier; 2006.
  • 14
    Desmet VJ, Gerber M., Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis grading and staging. Hepatology 1994;19:15131530.
  • 15
    Cole T., Center S., Flood S., et al. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc 2002;220:14831490.
  • 16
    Thornburg LP, Beissenherz M., Dolan M., et al. Histochemical demonstration of copper and copper-associated protein in the canine liver. Vet Pathol 1985;22:327332.
  • 17
    Thornberg LP, Rottinghaus M., McGowan M., et al. Hepatic copper concentrations in purebred and mixed-breed dogs. Vet Pathol 1990;27:8188.
  • 18
    Johnson GF, Gilbertson SR, Goldfischer PS, et al. Cytochemical detection of inherited copper toxicosis of Bedlington terriers Vet Pathol 1984; 21: 5760.
  • 19
    Child CG, Turcotte JG. Surgery and portal hypertension. In: ChildCG, ed. The Liver and Portal Hypertension. Philadelphia , PA : WB Saunders; 1964: 50.
  • 20
    Strombeck DR, Miller LM, Harrold D. Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (19771985). J Am Vet Med Assoc 1988;9: 11091117.
  • 21
    Sevelius E. Diagnosis and prognosis of chronic hepatitis and cirrhosis in dogs. J Small Anim Pract 1995;36:521528.
  • 22
    Thornberg L. A perspective on copper and liver disease in the dog. Vet Pathol 2000;12:101110.
  • 23
    Miyamura H., Nakanuma Y., Kono N. Survey of copper granules in liver biopsy specimens from various liver biopsy specimens from various liver abnormalities other than Wilson's disease and biliary disease. Gastroenterol Jpn 1988;23:633638.
  • 24
    Owen CA, Dickson ER, Goldstein HP, et al. Hepatic subcellular distribution of copper in primary biliary cirrhosis: comparison with other hyperhepatocupric states and review of the literature. Mayo Clin Proc 1977;52:7380.
  • 25
    Mallery KF, Freeman LM, Harpster NK, et al. Factors contributing to the euthanasia decision in dogs with congestive heart failure. J Am Vet Med Assoc 1999;214:12011204.
  • 26
    Sevelius E., Anderson M. Serum protein electrophoresis as a prognostic marker of chronic liver disease in the dog. Vet Rec 1995;23:663667.
  • 27
    Christensen E. Prognostic models including the Child-Pugh, MEDL and Mayo risk scores—Where are we and where should we go. J Hepatol 2004;41:344350.
  • 28
    Durand F., Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatology 2005; S100107.
  • 29
    Kamath P., Wiesner R., Malinshoc M., et al. A model to predict survival in patients with end stage liver disease Hepatology 2001; 33: 464470.